Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Oct-24 4:10 PM View:  | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 10-Oct-24 | Sale (Planned) | 8,260 | $15.09 | $124,603.00 | (3%) 322.97K to 314.71K | |
| 11-Oct-24 4:10 PM View: | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 09-Oct-24 | Sale (Planned) | 5,563 | $15.01 | $83,507.30 | (2%) 328.53K to 322.97K | |
| 19-Sep-24 4:35 PM View: | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 18-Sep-24 | Sale (Planned) | 10,676 | $12.09 | $129,091.00 | (3%) 339.2K to 328.53K | |
| 19-Sep-24 4:35 PM View: | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 17-Sep-24 | Sale (Planned) | 30,788 | $11.81 | $363,736.00 | (8%) 369.99K to 339.2K | |
| 16-Sep-24 4:05 PM View: | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 12-Sep-24 | Sale (Planned) | 32,948 | $11.43 | $376,665.00 | (8%) 402.94K to 369.99K | |
| 27-Aug-24 5:58 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 27-Aug-24 | Sale (Planned) | 15,693 | $11.39 | $178,806.00 | (7%) 239.66K to 223.97K | |
| 26-Aug-24 6:17 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 26-Aug-24 | Sale (Planned) | 31,642 | $11.78 | $372,588.00 | (12%) 271.3K to 239.66K | |
| 26-Aug-24 6:17 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 23-Aug-24 | Sale (Planned) | 24,169 | $11.59 | $280,005.00 | (8%) 295.47K to 271.3K | |
| 26-Aug-24 6:17 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 22-Aug-24 | Sale (Planned) | 28,496 | $11.63 | $331,468.00 | (9%) 323.96K to 295.47K | |
| 14-Jun-24 4:13 PM View: | Fust Matthew K Director | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | 100% 0 to 20.1K | |
| 14-Jun-24 4:18 PM View: | Ho Maykin Director | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | 100% 0 to 20.1K | |
| 14-Jun-24 4:11 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | < 1% 31.96M to 31.98M | |
| 14-Jun-24 4:14 PM View: | Halawa Alaa Director | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | 100% 0 to 20.1K | |
| 14-Jun-24 4:16 PM View: | Piacquad David Director | Neumora Therapeutics, Inc. (NMRA) | 13-Jun-24 | Grant | 20,100 | -- | -- | 100% 0 to 20.1K | |
| 24-Apr-24 5:00 PM View: | Aurora Daljit Singh Chief Strategy Officer | Neumora Therapeutics, Inc. (NMRA) | 22-Apr-24 | Gift | 114,703 | -- | -- | (35%) 326.91K to 212.2K | |
| 28-Jun-24 9:00 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 17-Apr-24 | Gift | 238,965 | -- | -- | (42%) 562.93K to 323.96K | |
| 16-Feb-24 4:21 PM View: | Pinto Joshua Chief Financial Officer | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 85,000 | -- | -- | 36% 238.97K to 323.96K | |
| 16-Feb-24 4:17 PM View: | Berns Paul L Director | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 171,250 | -- | -- | 2% 7.65M to 7.82M | |
| 16-Feb-24 4:13 PM View: | Lenz Robert A. Head of R&D | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 50,000 | -- | -- | 14% 352.94K to 402.94K | |
| 16-Feb-24 4:14 PM View: | Milligan Michael Lee See Remarks | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 20,625 | -- | -- | 539% 3.82K to 24.45K | |
| 16-Feb-24 4:20 PM View: | Aurora Daljit Singh Chief Strategy Officer | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 97,500 | -- | -- | 85% 114.7K to 212.2K | |
| 16-Feb-24 4:15 PM View: | Gosebruch Henry O President & CEO Director | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 80,000 | -- | -- | 15% 524.79K to 604.79K | |
| 16-Feb-24 4:19 PM View: | Suh Carol Y. Chief Operating Officer | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 85,000 | -- | -- | 29% 289.67K to 374.67K | |
| 12-Dec-23 7:52 PM View: | Arch Venture Partners X, LLC 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Dec-23 | Acquisition (other) Duplicate | 1,879,650 | -- | -- | 6% 30.05M to 31.93M | |
| 12-Dec-23 7:52 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Dec-23 | Acquisition (other) | 1,879,650 | -- | -- | 6% 31.88M to 33.76M | |
| 12-Dec-23 7:53 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Dec-23 | Acquisition (other) Duplicate | 1,879,650 | -- | -- | 6% 30.05M to 31.93M | |
| 12-Dec-23 7:52 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Dec-23 | Acquisition (other) | 13,997 | -- | -- | < 1% 33.76M to 33.77M | |
| 15-Nov-23 6:55 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 14-Nov-23 | Purchase Duplicate | 3,357 | $11.98 | $40,216.90 | < 1% 4.14M to 4.14M | |
| 15-Nov-23 6:54 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 14-Nov-23 | Purchase | 3,357 | $11.98 | $40,216.90 | < 1% 4.13M to 4.13M | |
| 15-Nov-23 6:54 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 13-Nov-23 | Purchase | 31,653 | $11.75 | $371,923.00 | < 1% 4.1M to 4.13M | |
| 15-Nov-23 6:55 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 13-Nov-23 | Purchase Duplicate | 31,653 | $11.75 | $371,923.00 | < 1% 4.11M to 4.14M | |
| 13-Nov-23 7:01 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 10-Nov-23 | Purchase Duplicate | 17,275 | $11.49 | $198,481.00 | < 1% 4.09M to 4.11M | |
| 13-Nov-23 7:00 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 10-Nov-23 | Purchase | 17,275 | $11.49 | $198,481.00 | < 1% 4.08M to 4.1M | |
| 13-Nov-23 7:01 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 09-Nov-23 | Purchase Duplicate | 31,079 | $10.53 | $327,262.00 | < 1% 4.06M to 4.09M | |
| 13-Nov-23 7:00 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 09-Nov-23 | Purchase | 31,079 | $10.53 | $327,262.00 | < 1% 4.05M to 4.08M | |
| 13-Nov-23 7:00 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Nov-23 | Purchase | 92,251 | $11.03 | $1,017,820.00 | 2% 3.96M to 4.05M | |
| 13-Nov-23 7:01 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 08-Nov-23 | Purchase Duplicate | 92,251 | $11.03 | $1,017,820.00 | 2% 3.97M to 4.06M | |
| 07-Nov-23 7:00 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 07-Nov-23 | Purchase Duplicate | 30,192 | $11.50 | $347,208.00 | < 1% 3.94M to 3.97M | |
| 07-Nov-23 6:59 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 07-Nov-23 | Purchase | 30,192 | $11.50 | $347,208.00 | < 1% 3.93M to 3.96M | |
| 07-Nov-23 7:00 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 06-Nov-23 | Purchase Duplicate | 43,082 | $11.55 | $497,597.00 | 1% 3.9M to 3.94M | |
| 07-Nov-23 6:59 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 06-Nov-23 | Purchase | 43,082 | $11.55 | $497,597.00 | 1% 3.88M to 3.93M | |
| 07-Nov-23 6:59 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 03-Nov-23 | Purchase | 22,420 | $11.38 | $255,140.00 | < 1% 3.86M to 3.88M | |
| 07-Nov-23 7:00 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 03-Nov-23 | Purchase Duplicate | 22,420 | $11.38 | $255,140.00 | < 1% 3.87M to 3.9M | |
| 29-Sep-23 6:55 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 29-Sep-23 | Purchase Duplicate | 34,560 | $13.98 | $483,149.00 | < 1% 3.84M to 3.87M | |
| 29-Sep-23 6:53 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 29-Sep-23 | Purchase | 34,560 | $13.98 | $483,149.00 | < 1% 3.83M to 3.86M | |
| 29-Sep-23 6:55 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 28-Sep-23 | Purchase Duplicate | 41,951 | $13.44 | $563,699.00 | 1% 3.8M to 3.84M | |
| 29-Sep-23 6:53 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 28-Sep-23 | Purchase | 41,951 | $13.44 | $563,699.00 | 1% 3.78M to 3.83M | |
| 27-Sep-23 8:18 PM View: | Arch Venture Partners Xii, ... 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 27-Sep-23 | Purchase | 24,504 | $12.31 | $301,644.00 | < 1% 3.76M to 3.78M | |
| 27-Sep-23 8:19 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 27-Sep-23 | Purchase Duplicate | 24,504 | $12.31 | $301,644.00 | < 1% 3.77M to 3.8M | |
| 27-Sep-23 8:19 PM View: | Burow Kristina Director 10% Owner | Neumora Therapeutics, Inc. (NMRA) | 26-Sep-23 | Purchase Duplicate | 34,000 | $11.73 | $398,820.00 | < 1% 3.74M to 3.77M |
